Clinical Diagnostic Laboratory Experience With Alzheimer’s Disease Blood Biomarker Testing: Insights Into Healthcare Provider Test Utilization and Patient Results (P7-3.012)
To analyze real-world HCP utilization of a high performing Alzheimer’s disease (AD) blood biomarker (BBM) test.
Authors
- Philip B. Verghese (ORCID: https://orcid.org/0000-0003-4793-564X)
- Tim West (ORCID: https://orcid.org/0000-0003-3267-8249)
- Justine Coppinger (ORCID: https://orcid.org/0009-0000-4137-930X)
- Joel B. Braunstein (ORCID: https://orcid.org/0000-0002-1155-0206)
- Sheena K. Aurora (ORCID: https://orcid.org/0000-0002-9425-1710)
- Sutapa Ray (ORCID: https://orcid.org/0000-0003-4234-2124)
Institutions
- C2N Diagnostics (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211995
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00